This provider's $71.5M in total Medicare payments ranks in the 99th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 203% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 129% in 2019
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $3.70 | $1.34 | 2.76x | $2.36 | $3.5M | 2.6M | 95 |
| 2015 | $3.05 | $1.14 | 2.68x | $1.91 | $3.3M | 2.9M | 99 |
| 2016 | $2.71 | $0.98 | 2.77x | $1.73 | $2.9M | 2.9M | 99 |
| 2017 | $2.90 | $1.07 | 2.71x | $1.83 | $2.6M | 2.4M | 92 |
| 2018 | $3.61 | $1.43 | 2.52x | $2.18 | $2.8M | 2.0M | 100 |
| 2019 | $9.90 | $5.48 | 1.81x | $4.42 | $6.4M | 1.2M | 108 |
| 2020 | $22.29 | $11.68 | 1.91x | $10.61 | $8.7M | 743.7K | 115 |
| 2021 | $42.19 | $26.43 | 1.60x | $15.76 | $17.4M | 657.3K | 123 |
| 2022 | $34.31 | $21.84 | 1.57x | $12.47 | $13.4M | 611.5K | 107 |
| 2023 | $23.11 | $14.01 | 1.65x | $9.10 | $10.6M | 755.0K | 110 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81408 | Molecular pathology procedure level 9 | 3.4K | $6.8M | $2.0K | 1.25x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 52.7K | $4.3M | $82.09 | 3.05x |
| 81411 | Test for detecting genes associated with heart disease, duplication/deletion analysis panel | 2.8K | $3.8M | $1.3K | 1.11x |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis | 5.0K | $3.3M | $665.37 | 1.03x |
| 81238 | Gene analysis (coagulation factor ix) full sequence analysis | 5.3K | $3.2M | $594.58 | 1.14x |
| 81307 | Gene analysis (partner and localizer of brca2) full sequence analysis | 4.1K | $2.6M | $633.42 | 1.02x |
| 81298 | Gene analysis (muts homolog 6 [e coli]) full sequence analysis | 4.0K | $2.5M | $630.99 | 1.02x |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 392.5K | $2.4M | $6.23 | 1.71x |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 383.2K | $2.0M | $5.16 | 2.01x |
| 81249 | Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis | 3.3K | $1.9M | $591.12 | 1.03x |
| 81201 | Gene analysis (adenomatous polyposis coli), full gene sequence | 2.4K | $1.7M | $701.91 | 1.03x |
| 81439 | Test for detecting genes associated with inherited disease of heart muscle | 2.9K | $1.7M | $584.90 | 1.37x |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | 77.1K | $1.6M | $20.19 | 3.07x |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 14.1M | $1.5M | $0.11 | 1.06x |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | 141.1K | $1.4M | $10.15 | 3.45x |
| 81223 | Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence | 2.8K | $1.4M | $490.32 | 1.02x |
| 80053 | Blood test, comprehensive group of blood chemicals | 114.4K | $1.4M | $11.99 | 3.62x |
| 81410 | Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 9 genes | 2.7K | $1.4M | $504.00 | 1.29x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 128.8K | $1.2M | $9.51 | 3.33x |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 52.4K | $1.2M | $23.37 | 1.00x |
This provider submits charges 1.89 times higher than what Medicare actually pays.
A markup ratio of 1.89x means for every $100 Medicare pays, this provider initially charges $189. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in PA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc | Norristown, PA | $340.6M | ✓ Clear |
| Quest Diagnostics Of Pennsylvania, Inc. | Pittsburgh, PA | $130.4M | ⚠️ Flagged |
| Health Network Laboratories, Llc | Allentown, PA | $125.3M | ⚠️ Flagged |
| Sma Medical, Inc. | Feasterville, PA | $100.9M | ✓ Clear |
| Interpace Diagnostics Corporation | Pittsburgh, PA | $95.6M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data